Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes.
Williams
K V
KV
The Department of Medicine, University of Pittsburgh, PA 15261, USA. kelley@med1.dept-med.pitt.edu
Kelley
D E
DE
D000273:Adipose Tissue / Q000033:anatomy & histology; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000178:diet therapy* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D004038:Diet, Reducing; D004734:Energy Metabolism; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D007333:Insulin Resistance; D000078790:Insulin Secretion; D020738:Leptin / Q000378:metabolism; D018482:Muscle, Skeletal / Q000378:metabolism; D009765:Obesity; D012307:Risk Factors; D015431:Weight Loss / Q000502:physiology*
D019440:Anti-Obesity Agents; D007328:Insulin; D020738:Leptin; D005947:Glucose